Crossmark

Self-Management Strategies for Treating Pediatric and Adolescent Headaches and Migraines with Over-the-Counter Molecules: Expert Opinion and Literature Review

Crossref DOI link: https://doi.org/10.1007/s40122-025-00783-x

Published Online: 2025-10-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Oakley, Christopher

Kachroo, Preeti https://orcid.org/0000-0003-1058-4962
Mitra, Ashoke

Bell, John
License Information

Text and Data Mining valid from 2025-10-11

Version of Record valid from 2025-10-11
More Information

Article History

Received: 26 June 2025

Accepted: 26 September 2025

First Online: 11 October 2025

Declarations

:

: Christopher Oakley has received honoraria from the Southern Headache Society and American Academy of Pediatrics; receives royalties from Springer (for Pediatric Headache, 1st ed. manuscript); is a board member of the Southern Headache Society; on the Examination Committee and Accreditation Committee UCNS / Headache Medicine. Preeti Kachroo is an employee of Haleon PLC. Ashoke Mitra is an employee of Haleon PLC; holds stock or stock options with Haleon. John Bell is a consultant for Bayer, GlaxoSmithKline, Mylan, Novartis, Pfizer, Procter and Gamble. Reckitt Benckiser has received support from Bayer, Haleon, Mylan, Procter and Gamble; participated in data safety monitoring or ad board for GlaxoSmithKline; has received honoraria and support from iNova, GlaxoSmithKline, Pfizer, and Reckitt Benckiser; holds a leadership/fiduciary role in The Pharmaceutical Society of Australia and The Australian Self Care Alliance; and has financial/non-financial interests in The University of Technology Sydney.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.

Document is current

Any future updates will be listed below